"PRRT: What We Know, Special Considerations & Clinical Trials" with Dr. Strosberg • Jan 11, 2024

  Рет қаралды 1,744

LACNETS

LACNETS

5 ай бұрын

Learn the latest on PRRT with NET expert Dr. Jonathan Strosberg. Dr Strosberg was the principal investigator of the NETTER-1 study which led to the FDA approval of Lutathera and has authored numerous articles on PRRT. He will discuss the latest in PRRT, including special considerations and current clinical trials.
Visit LACNETS.org for more information.

Пікірлер: 2
@virginiasmith5371
@virginiasmith5371 3 ай бұрын
I had difficult side effects after receiving octreotide injection: hallucinations, diarrhea, high blood pressure. What do I have to avoid in continued therapies?
@zacharycat603
@zacharycat603 Ай бұрын
I had rather severe pain during and after the injections. Then before the last one the nurse warmed the medicine rather than injecting it cold, and I felt no pain or after effects. No idea that such a small thing could make so much difference.
A 2023 Update on CAR-T Therapy in Myeloma with Dr. Craig Hofmeister
1:03:49
HealthTree Foundation for Multiple Myeloma
Рет қаралды 9 М.
버블티로 체감되는 요즘 물가
00:16
진영민yeongmin
Рет қаралды 32 МЛН
Они убрались очень быстро!
00:40
Аришнев
Рет қаралды 3,4 МЛН
Khóa ly biệt
01:00
Đào Nguyễn Ánh - Hữu Hưng
Рет қаралды 19 МЛН
Making Rounds: Medical Education Documentary Film
1:03:18
Mount Sinai Health System
Рет қаралды 6 МЛН
What You Need to Know about Non-Hodgkin's Lymphoma: Presentation
36:58
CAR T-cell Therapy: The Good, The Bad and The Long-Term 2022
59:12
Intro to Neuroendocrine Tumors  (Chih-Yi (Andy) Liao, MD)
18:40
Lung Cancer New Treatment 2023
47:57
Stanley Kim
Рет қаралды 26 М.
Atrial Fibrillation: New Solutions for an Old Problem
38:36
UT Health East Texas
Рет қаралды 2,8 МЛН
ABCs of Neuroendocrine Cancer: 2020 Update
13:35
Carcinoid Cancer Foundation
Рет қаралды 33 М.
Webinar - Disruptive Mood Dysregulation Disorder (DMDD): Background & Treatment (Saundra Stock, MD)
54:56
Florida Program for BH Improvement and Solutions
Рет қаралды 9 М.
The Continuing Success Story of Immunotherapy in NSCLC
1:27:28
PeerView Oncology
Рет қаралды 1,5 М.
버블티로 체감되는 요즘 물가
00:16
진영민yeongmin
Рет қаралды 32 МЛН